Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 961 AL 975

New approaches to symptomatic treatments for Alzheimer's disease

Cummings J.

Mol Neurodegener. 2021 Jan 13;16(1):2. doi: 10.1186/s13024-021-00424-9.

Preservation of Memory in Alzheimer-Related Primary Progressive Aphasia: Glass Half Full

Sajjadi SA, Ash S, Cappa S.

Neurology. 2021 Feb 9;96(6):243-244. doi: 10.1212/WNL.0000000000011404. Epub 2021 Jan 13.

Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy

Liguori C, Spanetta M, Romoli M, Placidi F, Nardi Cesarini E, Mercuri NB, Costa C.

Mech Ageing Dev. 2021 Mar;194:111434. doi: 10.1016/j.mad.2021.111434. Epub 2021 Jan 11.

Classification accuracy of TMS for the diagnosis of mild cognitive impairment

Benussi A, Grassi M, Palluzzi F, Cantoni V, Cotelli MS, Premi E, Di Lorenzo F, Pellicciari MC, Ranieri F, Musumeci G, Marra C, Manganotti P, Nardone R, Di Lazzaro V, Koch G, Borroni B.

Brain Stimul. 2021 Mar-Apr;14(2):241-249. doi: 10.1016/j.brs.2021.01.004. Epub 2021 Jan 13.

Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease

Loeffler DA.

J Alzheimers Dis. 2021;80(1):1-27. doi: 10.3233/JAD-201182.

The Fragility of Temporal Memory in Alzheimer's Disease

Park JH, Lee SA.

J Alzheimers Dis. 2021;79(4):1631-1646. doi: 10.3233/JAD-200892.

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism

Cho S, Lee H, Seo J.

Mol Neurobiol. 2021 Jun;58(6):2608-2619. doi: 10.1007/s12035-021-02297-x. Epub 2021 Jan 21.

Efficacy of cognitive intervention programs in amnesic mild cognitive impairment: A systematic review

Gómez-Soria I, Peralta-Marrupe P, Calatayud-Sanz E, Latorre E.

Arch Gerontol Geriatr. 2021 May-Jun;94:104332. doi: 10.1016/j.archger.2020.104332. Epub 2021 Jan 14.

Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes

Grober E, Qi Q, Kuo L, Hassenstab J, Perrin RJ, Lipton RB.

J Alzheimers Dis. 2021;80(1):185-195. doi: 10.3233/JAD-200946.

Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation

Ribarič S.

Int J Mol Sci. 2021 Jan 22;22(3):1102. doi: 10.3390/ijms22031102.

The Role of Acupuncture Improving Cognitive Deficits due to Alzheimer's Disease or Vascular Diseases through Regulating Neuroplasticity

Ji S, Duan J, Hou X, Zhou L, Qin W, Niu H, Luo S, Zhang Y, Chan P, Jin X.

Neural Plast. 2021 Jan 12;2021:8868447. doi: 10.1155/2021/8868447. eCollection 2021.

Brief Cognitive Testing in the Detection and Diagnosis of Clinical Alzheimer-Type Dementia

Saguil A, Buck E.

Am Fam Physician. 2021 Feb 1;103(3):183-185.

Intranasal Insulin for Alzheimer's Disease

Hallschmid M.

CNS Drugs. 2021 Jan;35(1):21-37. doi: 10.1007/s40263-020-00781-x. Epub 2021 Jan 30.

Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARIC

Gianattasio KZ, Bennett EE, Wei J, Mehrotra ML, Mosley T, Gottesman RF, Wong DF, Stuart EA, Griswold ME, Couper D, Glymour MM, Power MC; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2021 Aug;17(8):1265-1276. doi: 10.1002/alz.12293. Epub 2021 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias